Vaishali Pharma Ltd Stock Price Today (NSE: VAISHALI)
Fundamental Score
Vaishali Pharma Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Vaishali Pharma Ltd share price today is ₹7.64, up +3.95% on NSE/BSE as of 3 August 2026. Vaishali Pharma Ltd (VAISHALI) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹101.24 (Cr). The 52-week high for VAISHALI share price is ₹13.05 and the 52-week low is ₹4.75. At a P/E ratio of 24.34x, VAISHALI is currently trading below its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 6.02% and a debt-to-equity ratio of 0.27.
Vaishali Pharma Ltd Share Price Chart — NSE/BSE Historical Performance
Vaishali Pharma Ltd share price chart: -0.81% return over the past month. 52-week high ₹13.05, 52-week low ₹4.75.
Vaishali Pharma Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹7.21 | ₹7.43 | ₹7.21 | ₹7.35 | 64.06K (Cr) | |
| ₹7.76 | ₹7.76 | ₹7.40 | ₹7.47 | 51.95K (Cr) | |
| ₹7.98 | ₹7.98 | ₹6.96 | ₹7.39 | 9.21L (Cr) | |
| ₹8.00 | ₹8.14 | ₹7.38 | ₹7.72 | 60.70K (Cr) | |
| ₹7.82 | ₹8.08 | ₹7.55 | ₹7.83 | 66.92K (Cr) | |
| ₹8.05 | ₹8.05 | ₹7.75 | ₹7.82 | 25.46K (Cr) | |
| ₹7.88 | ₹8.18 | ₹7.72 | ₹7.84 | 23.49K (Cr) | |
| ₹7.72 | ₹8.10 | ₹7.52 | ₹7.88 | 86.71K (Cr) | |
| ₹8.00 | ₹8.15 | ₹7.90 | ₹8.04 | 86.27K (Cr) | |
| ₹7.70 | ₹7.93 | ₹7.70 | ₹7.93 | 1.91L (Cr) |
Vaishali Pharma Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹7.20 | ₹8.18 | ₹6.96 | ₹7.35 | +2.08% | |
| ₹7.29 | ₹7.89 | ₹6.81 | ₹7.21 | -1.10% | |
| ₹7.76 | ₹7.90 | ₹6.72 | ₹7.05 | -9.15% | |
| ₹5.00 | ₹9.30 | ₹5.00 | ₹7.61 | +52.20% | |
| ₹7.19 | ₹7.19 | ₹4.75 | ₹4.88 | -32.13% | |
| ₹8.05 | ₹8.30 | ₹6.81 | ₹6.97 | -13.42% | |
| ₹8.83 | ₹9.80 | ₹7.93 | ₹7.97 | -9.74% | |
| ₹8.85 | ₹9.78 | ₹7.75 | ₹8.62 | -2.60% | |
| ₹10.19 | ₹10.27 | ₹8.51 | ₹8.79 | -13.74% | |
| ₹11.55 | ₹11.88 | ₹9.00 | ₹10.04 | -13.07% | |
| ₹12.30 | ₹12.70 | ₹11.12 | ₹11.31 | -8.05% | |
| ₹12.90 | ₹13.05 | ₹11.85 | ₹12.24 | -5.12% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Vaishali Pharma Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Vaishali Pharma Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of VAISHALI across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Attractive Valuation (P/E: 24.34 vs Industry: 34.89)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Conservative Debt Levels (D/E: 0.27)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
2 factors identified
Below-Average Return on Equity (6.02%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Vaishali Pharma Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Vaishali Pharma Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
7.3/100 | ₹7.64₹8 | ₹101.24₹101.24 | 24.34Average 24.3 Average | 6.02%Poor 6.02% Poor | — — | 0.27Excellent 0.3 Excellent | — — | — — | 0.00% | |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1990.50₹1991 | ₹468821.49₹468821.49 | 37.73Average 37.7 Average | 15.95%Good 15.95% Good | 20.53%Excellent 20.53% Excellent | 0.06Excellent 0.1 Excellent | 16.75%Excellent 16.75% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 56.3/100 | ₹8056.00₹8056 | ₹193163.97₹193163.97 | 73.64Average 73.6 Average | 16.53%Good 16.53% Good | 21.96%Excellent 21.96% Excellent | 0.00Excellent 0.0 Excellent | 5.71%Good 5.71% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹5122.80₹5123 | ₹169902.02₹169902.02 | 77.52Average 77.5 Average | 27.43%Excellent 27.43% Excellent | 15.19%Good 15.19% Good | 1.79Average 1.8 Average | 12.07%Good 12.07% Good | 11.80%Good 11.80% Good | 0.76% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 40.2/100 | ₹1473.20₹1473 | ₹116131.81₹116131.81 | 30.51Average 30.5 Average | 11.60%Average 11.60% Average | 15.49%Good 15.49% Good | 0.02Excellent 0.0 Excellent | 9.94%Good 9.94% Good | 8.01%Good 8.01% Good | 0.90% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1078.30₹1078 | ₹115375.77₹115375.77 | 21.26Average 21.3 Average | 21.25%Excellent 21.25% Excellent | 21.14%Excellent 21.14% Excellent | 0.46Excellent 0.5 Excellent | 18.77%Excellent 18.77% Excellent | 12.45%Good 12.45% Good | 0.09% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 83.4/100 | ₹2415.00₹2415 | ₹113976.53₹113976.53 | 20.04Average 20.0 Average | 28.68%Excellent 28.68% Excellent | 29.93%Excellent 29.93% Excellent | 0.29Excellent 0.3 Excellent | 37.02%Excellent 37.02% Excellent | 13.02%Good 13.02% Good | 0.72% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2469.60₹2470 | ₹105053.91₹105053.91 | 52.29Average 52.3 Average | 13.12%Average 13.12% Average | 13.50%Average 13.50% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 41/100 | ₹1148.10₹1148 | ₹102660.46₹102660.46 | 25.62Average 25.6 Average | 11.22%Average 11.22% Average | 13.04%Average 13.04% Average | 0.20Excellent 0.2 Excellent | 15.44%Excellent 15.44% Excellent | 12.09%Good 12.09% Good | 0.65% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1580.20₹1580 | ₹90035.87₹90035.87 | 25.38Average 25.4 Average | 10.06%Average 10.06% Average | 12.80%Average 12.80% Average | 0.21Excellent 0.2 Excellent | 0.80%Average 0.80% Average | 6.32%Good 6.32% Good | 0.26% |
Laurus Labs LtdLaurus Labs Ltd... LAURUSLABS • 540222 | 34.1/100 | ₹1816.20₹1816 | ₹84016.75₹84016.75 | 93.94Average 93.9 Average | 18.30%Good 18.30% Good | 17.76%Good 17.76% Good | 0.48Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price468821.49 Cr
- Divis Laboratories Ltd share price193163.97 Cr
- Torrent Pharmaceuticals Ltd share price169902.02 Cr
- Cipla Ltd share price116131.81 Cr
- Zydus Lifesciences Ltd share price115375.77 Cr
Vaishali Pharma Ltd PE Ratio History
Historical price-to-earnings ratio for VAISHALI — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹0.06 | ₹17.49 | 273.3x |
| FY 2023 | ₹0.59 | ₹18.20 | 30.8x |
| FY 2022 | ₹0.38 | ₹13.87 | 36.3x |
| FY 2021 | ₹0.10 | ₹3.58 | 36.2x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Vaishali Pharma Ltd Quarterly Performance
Latest quarterly metrics for VAISHALI — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
N/A
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
N/A
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Vaishali Pharma Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for VAISHALI — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Vaishali Pharma Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Vaishali Pharma Ltd (VAISHALI) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Vaishali Pharma Ltd
About VAISHALI (Vaishali Pharma Ltd)
Vaishali Pharma Ltd is a dynamic pharmaceutical company committed to developing, manufacturing, and distributing a wide range of high-quality pharmaceutical products. Focused on im...proving patient health and well-being, Vaishali operates with a dedication to innovation, scientific rigor, and ethical practices. The company strives to meet the evolving healthcare needs of communities globally by offering a comprehensive portfolio of medications. Vaishali Pharma is dedicated to creating affordable and accessible solutions for various medical conditions. Through continuous research and development, state-of-the-art manufacturing facilities, and a strong commitment to quality, Vaishali Pharma aspires to be a trusted partner in healthcare. Vaishali Pharma's product line encompasses an extensive array of therapeutic categories designed to address a multitude of health concerns. The company produces and markets essential drugs covering areas such as infectious diseases, pain management, respiratory illnesses, cardiovascular health, and metabolic disorders. Vaishali’s broad portfolio includes both generic medications and specialized formulations, ensuring a wide reach and accessibility for patients. Committed to maintaining the highest standards, Vaishali Pharma adheres to stringent quality control measures throughout the production process, from raw material sourcing to final product packaging. This commitment guarantees that all products are safe, effective, and meet the rigorous requirements of regulatory bodies. Vaishali Pharma's global reach extends to numerous markets, allowing it to make a significant impact on healthcare systems around the world. The company is dedicated to expanding its presence through strategic partnerships, innovative product development, and a steadfast focus on customer satisfaction. Vaishali emphasizes strong relationships with healthcare professionals, distributors, and regulatory agencies to ensure its medications reach those who need them most. By fostering a culture of excellence and continuous improvement, Vaishali Pharma strives to remain at the forefront of the pharmaceutical industry, constantly seeking new ways to improve patient outcomes and contribute to a healthier future.
Company Details
Key Leadership
Latest News
VAISHALI Share Price: Frequently Asked Questions
What is the current share price of Vaishali Pharma Ltd?
Vaishali Pharma Ltd (VAISHALI) trades at ₹7.64 on NSE. Market cap ₹101.24 (Cr). Educational data only.
What is the P/E ratio of Vaishali Pharma Ltd?
Vaishali Pharma Ltd has a P/E of 24.34x vs industry average 34.89x.
What is the Bull Run score for Vaishali Pharma Ltd?
Vaishali Pharma Ltd has a Bull Run score of 7.3/100 based on 25+ financial parameters.
Does Vaishali Pharma Ltd pay dividends?
Vaishali Pharma Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Vaishali Pharma Ltd?
Vaishali Pharma Ltd has ROE of 6.02%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Vaishali Pharma Ltd?
Vaishali Pharma Ltd has debt-to-equity of 0.27.
Is Vaishali Pharma Ltd a good investment?
Bull Run gives Vaishali Pharma Ltd a score of 7.3/100. This is not investment advice — consult a SEBI-registered advisor.